Table 1.
Parameter | Base case | Lower | Upper | Probabilistic distribution | Source |
General model settings | |||||
Patient age (all populations) | 40 | Assumption | |||
Annual discount rate | 3% | Neumann11 | |||
Sensitivity analyses, range % +/- | 25% | Assumption | |||
Number of probabilistic analysis simulations | 5,000 | Assumption | |||
Prefunctional decline population assumptions | |||||
CAG repeats | 40 | Advisory board | |||
Total functional capacity (TFC) score | 13 | Advisory board | |||
Total motor score (TMS)a | 2 | Advisory board | |||
Symbol digit modalities test (SDMT) scorea | 50 | Advisory board | |||
Natural history outcomes for SF1 (TFC 13-11) | |||||
Total functional capacity (TFC) score baseline | 12.2 | TRACK-HD16 | |||
TFC 12-mo Δ | −0.910 | −1.360 | −0.620 | Normal | TRACK-HD16 |
TFC 36-mo Δ | −1.989 | Correlated | TRACK-HD17 | ||
Annual TFC transition probabilityb | 0.651 | Varies with SLRc | SLR-derivedc | ||
Natural history outcomes for SF2 (TFC 10-7) | |||||
Total functional capacity (TFC) score baseline | 8.7 | TRACK-HD16 | |||
TFC 12-mo Δ | −0.440 | −0.780 | −0.130 | Normal | TRACK-HD16 |
TFC 36-mo Δ | −1.974 | Correlated | TRACK-HD17 | ||
Annual TFC transition probability | 0.669 | Varies with SLRc | SLR-derivedc | ||
Health state utilities | |||||
Premanifest | 0.86 | 0.84 | 0.87 | Beta | Jiang27 |
Shoulson and Fahn stage 1 (TFC 11–13) | 0.78 | 0.72 | 0.85 | Beta | Rodríguez-Santana28 |
Shoulson and Fahn stage 2 (TFC 7–10) | 0.66 | 0.59 | 0.73 | Beta | Rodríguez-Santana28 |
Shoulson and Fahn stage 3 (TFC 3–6) | 0.54 | 0.48 | 0.61 | Beta | Rodríguez-Santana28 |
Shoulson and Fahn stage 4–5 (TFC 0–2) | 0.22 | 0.11 | 0.32 | Beta | Rodríguez-Santana28 |
Direct medical costs | |||||
Shoulson and Fahn stage 1 (TFC 13-11) | $13,183 | $5,723 | $20,644 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 2 (TFC 10-7) | $16,549 | $3,786 | $29,311 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 3 (TFC 6-3) | $20,189 | $5,404 | $34,974 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 4 (TFC 2-1) | $48,031 | $18,983 | $77,080 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 5 (TFC 0) | $25,217 | $0 | $55,668 | Log-normal | Rodríguez-Santana29 |
Societal costs | |||||
Shoulson and Fahn stage 1 (TFC 13-11) | $30,691 | $11,333 | $50,048 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 2 (TFC 10-7) | $41,676 | $15,390 | $67,962 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 3 (TFC 6-3) | $110,142 | $38,727 | $185,849 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 4 (TFC 2-1) | $58,561 | $1,724 | $115,398 | Log-normal | Rodríguez-Santana29 |
Shoulson and Fahn stage 5 (TFC 0) | $36,409 | $1,072 | $71,746 | Log-normal | Rodríguez-Santana29 |
For low-education (high school only) population.
Also used for the prefunctional decline (PFD) population once progression commences.
SLR = simple linear regression of TRACK-HD baseline, 1-year, and 3-year TFC scores.